
SELLAS Life Sciences Group Inc (SLS) with a beta value of 2.27 appears to be a promising investment opportunity.
On Monday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -3.01% from the last session, before settling in for the closing price of $1.66.